相关实验视频
Updated: Jul 12, 2025
10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.7K
评估神经瘤学临床试验的影响和价值:测试一种新的多标准决策分析应用程序
Kathryn Maree Field1, Mark Andrew Rosenthal1, Piers Gillett2
1Department of Medical Oncology, Peter MacCallum Cancer Centre (KF, MR), Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne (KF, MR), Australia.
概括
一个新的网络应用程序使用多标准决策分析 (MCDA) 来对临床试验价值进行排名,优先考虑患者的结果和未满足的需求. 该工具有助于将资源集中在高影响力神经瘤学试验上.
科学领域:
- 临床研究方法论临床研究方法论
- 卫生经济学和结果研究研究.
- 决策分析 决策分析
背景情况:
- 全球临床试验在资源分配和结果优先级方面存在挑战.
- 量化临床试验"价值"对于指导临床医生的重点和资源部署至关重要.
- 一个新的基于网络的应用程序被开发用于评估和排名的临床试验价值使用多标准决策分析 (MCDA).
研究的目的:
- 评估一款旨在对临床试验价值进行排名的新型基于网络的应用程序.
- 通过比较其排名与专家临床医生评估来确定MCDA工具的面值.
- 确定临床医生在评估临床试验价值时优先考虑的关键指标.
主要方法:
- 该工具整合了七个指标:未满足的需求,目标人群规模,访问,结果,成本,学术影响和结果的使用.
- 根据该应用程序对10项已发表的神经瘤学第三期临床试验进行了排名.
- 神经瘤学临床医生通过对相同的试验进行排名和七个指标的重要性来验证该应用程序.
主要成果:
- 该应用程序的前两个排名的试验与临床医生排名一致,并对神经瘤学临床实践产生了重大影响.
- 临床医生将患者的结果和未满足的需求确定为确定临床试验价值的最关键指标.
- MCDA工具成功地为现有的神经瘤学临床试验生成了数值"值".
结论:
- 开发的指标应用程序有效地根据计算值对神经瘤学临床试验进行第3期的排名.
- 未来的发展可能会导致在选址阶段优先考虑新的临床试验的潜在工具.
- 这项技术可以帮助研究中心优化行为试验的优先级.
相关概念视频
01:21Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:16Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
01:12Hazard Ratio
137
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
137
01:09Decision Making: P-value Method
5.4K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.4K